388870 — Pharos IBio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Pharos IBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-31,471	-17,062	-8,858	-10,560	-10,757
Depreciation
Amortisation
Non-Cash Items	24,285	8,107	-6.58	-381	691
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-484	193	767	811	880
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,319	-8,184	-7,413	-9,327	-8,347
Capital Expenditures	-1,481	-334	-855	-1,018	-42.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-76.7	-6,233	1,329	611	8,829
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,557	-6,567	474	-408	8,787
Financing Cash Flow Items	-2	—	—	—	-97.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	17,635	-271	18,805	-31.5	18,745
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9,005	-15,000	11,776	-9,228	19,173